close
  • home Home

  • linked_services Solutions keyboard_arrow_down

  • experiment Services keyboard_arrow_down

  • support Support & Resources keyboard_arrow_down

  • apartment Company keyboard_arrow_down

  • mail Contact

  • Solutions
    keyboard_arrow_down
  • Services
    keyboard_arrow_down
  • Support & Resources
    keyboard_arrow_down
  • Company
    keyboard_arrow_down
  • Contact
Randox Health search menu

The RIQAS Serology Syphilis EQA Programme is designed to monitor the performance of Syphilis tests using immunoassay RPR, VDRL and TPHA based methods. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative and qualitative methods of analysis

Liquid ready-to-use samples requiring minimal preparation

Monthly reporting to reduce the risk of errors

World's largest EQA scheme ensuring peer groups are maximised

Suitable for both quantitative and qualitative methods of analysis

Cycle Starts - July 2026

Not Accredited

Get in touch to discover more

To find out more about RIQAS EQA or to get in touch with your local Randox Representative, enquire now.

DescriptionFrequencySizeCat No
Serology SyphilisMonthly6 x 1 mlRQ9154

Parameter

  • Syphilis (Methods available include immunoassay RPR, VDRL and TPHA)

Please note, product availability may vary country to country.

Related RIQAS EQA Programmes

Serology (HIV Hepatitis)

Serology (ToRCH)

Serology Epstein Barr Virus (EBV)

Acusera QC
Complete QC Solutions for Results you Can Trust
RIQAS Brochure
Randox International Quality Assessment Scheme
QCMD
QCMD EQA/PT Schemes for Molecular Infectious Disease Testing.